Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Generic Labeling Rule Dies In Latest Reg Agenda, But Electronic Labeling Is Reborn

Executive Summary

US FDA also indicated plans to update definition of biologic product and propose a one-page Patient Medication Information in the latest Unified Agenda.

Advertisement

Related Content

Generic Labeling Problems Targeted In US FDA Budget Request
Antimicrobial Sponsors Should Update Labels Within Year Of Breakpoint Webpage Launch, US FDA Says
Sanofi's Admelog, a Humalog Follow-On, Approved In US As 'Black Hole' For Insulins Looms
Will Antimicrobial Breakpoint Changes Signal Shift To Online Labeling Updates?
Generic Labeling Rule Defies Predictions, Remains In FDA's Long-Term Pipeline
US Patient Medical Information Rule: Will It Be Delayed Again?
US FDA Likely Not 'Significant', Could Be Mostly Spared From Trump's Regulation-Slashing Order
BLAs More Appealing As 'Transition' NDAs, ANDAs Set To Lose Exclusivity
Label Change Proposal From GPhA, PhRMA Makes FDA Responsible For Timing
Electronic Prescribing Information: Proposed Rule May Not Completely Eliminate Paper

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

PS122153

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel